ID   SK-RC-56
AC   CVCL_6203
SY   SK RC 56; SKRC56
DR   Cosmic; 972886
DR   Wikidata; Q54954606
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 48 hours (PubMed=2386958).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D16S539: 9,13
ST   D18S51: 16
ST   D19S433: 12,15
ST   D21S11: 31
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
RX   PubMed=2386958;
RA   Ebert, Thomas
RA   Bander, Neil Harrison
RA   Finstad, Connie Lee
RA   Ramsawak, Rosemarie D.
RA   Old, Lloyd John
RT   "Establishment and characterization of human renal cancer and normal
RT   kidney cell lines.";
RL   Cancer Res. 50:5531-5536(1990).
//